Compare BIO & LEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | LEA |
|---|---|---|
| Founded | 1952 | 1917 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Auto Parts:O.E.M. |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.3B |
| IPO Year | 1994 | 1994 |
| Metric | BIO | LEA |
|---|---|---|
| Price | $386.11 | $134.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $339.75 | $132.21 |
| AVG Volume (30 Days) | 236.0K | ★ 520.9K |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 2.49% |
| EPS Growth | ★ 142.61 | N/A |
| EPS | N/A | ★ 7.13 |
| Revenue | $2,583,200,000.00 | ★ $23,259,100,000.00 |
| Revenue This Year | $2.74 | $2.50 |
| Revenue Next Year | $3.20 | $3.12 |
| P/E Ratio | ★ N/A | $18.34 |
| Revenue Growth | ★ 0.65 | N/A |
| 52 Week Low | $236.73 | $96.04 |
| 52 Week High | $396.23 | $150.33 |
| Indicator | BIO | LEA |
|---|---|---|
| Relative Strength Index (RSI) | 69.94 | 56.18 |
| Support Level | $287.41 | $126.85 |
| Resistance Level | $396.23 | $131.76 |
| Average True Range (ATR) | 11.10 | 2.72 |
| MACD | -0.93 | 1.18 |
| Stochastic Oscillator | 79.56 | 93.86 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns majority of its revenue from the seating segment.